Abstract: Disclosed is an atomic interferometer including a source of atoms, a laser source and a magnetic field generating device, a polarizer, a system for adjusting a detuning between two optical frequencies of the incident laser beam, a two-dimensional diffraction grating arranged in such a way as to receive the incident laser beam and to form by diffraction at least three diffracted beams, a controller configured to select a combination of an optical frequency detuning, a polarization state and a magnetic field, the combination being adapted to select a first pair of laser beams among the pairs of beams formed from the incident laser beam and the diffracted beams, the pair of laser beams being applied in such a way as to interact with the cloud of atoms by multi-photon transitions and to detect an acceleration of the cloud of atoms along a measurement direction.

Abstract: The invention relates to an optical device (1) for enhancing the resolution of an image or for reducing speckle noise.

Abstract: The present invention is an actuator that may be used to service a vehicle, where the actuator engages an accelerator pedal of the vehicle and can control the pedal remotely using a vehicle service module or tech station that automatically carries out a vehicle engine service. The actuator comprises a member that uses a linear actuator to engage the vehicle's accelerator pedal and controls the speed of the engine using feedback directly from the engine's ECU or other direct engine input. The pedal actuator include input cables that receive signals from the remote service module to adjust the speed of the engine to optimize a service performance. The data from the engine can include temperature, pressure, RPMs, and various other inputs depending on the service to be performed. The present invention allows the service technician to control the engine without the need for a second tech to apply pressure to the accelerator and monitor the engine speed.

Abstract: Methods and apparatus for enhanced power delivery between devices. In one embodiment, the power delivery is enhanced relative to legacy capabilities, and a source device negotiates with a sink device to establish a high-voltage (HV) power contract. In one variant, such HV operation enables power delivery greater than the legacy USB-C standard maximum of 20 V and 100 W. In one implementation, the source, sink, and/or source and sink collectively ensure that multiple criteria relating to power delivery are met for the interface (i.e., source, the sink, and the interposed cable or power delivery medium). Multiple conditions, including enclosure construction compliance and device capabilities, must be cleared to ensure safety while operating beyond standard maximums. If the criteria are met, HV validation is complete, and the source may offer HV operation to the sink to establish the HV contract. Additional fail-safe mechanisms enable the HV contract to discontinue upon triggering.

Abstract: Embodiments of the disclosure provide a method for operating a combined cycle power plant (CCPP). The method may include creating a variant control profile for the CCPP for a power plant model of the CCPP. The method may include modifying the variant control profile in response to the variant control profile not reducing the fuel consumption or meeting the quality threshold. The method may also include adjusting the CCPP to use the variant control profile in response to the variant control profile reducing the fuel consumption and meeting the quality threshold. Using the variant control profile adjusts a turbine section inlet temperature schedule or an exhaust temperature schedule for the CCPP.

Abstract: An implantable artificial capsule and a method of implantation are provided. The implantable artificial capsule has a ring with a central opening to accommodate an intraocular lens and at least three haptic arms extending substantially orthogonal from the outer surface of the ring. Each arm has transcleral anchors for sutureless scleral fixation. Upon implantation of the implantable artificial capsule the arms are externalized trans-sclerally and atraumatically. The arms sit subconjunctivally. The implantable artificial capsule does not have any sutures for fixation and is suturelessly implanted in an eye, which is a major advantage as it significantly reduces complications during surgery and recovery.

Abstract: Wnt signaling antagonist and agonist compositions and methods for their use are provided.

Abstract: Gaming systems that provide a tile selection and award determination sequence for a gaming environment.

Abstract: A telescopic side arm for a refuse vehicle has an inner and outer boom. A mounting assembly secures the outer boom with a refuse vehicle. A plurality of bearing pads is positioned between the inner and outer booms to provide smooth movement between the inner and outer booms. A plurality of shims is associated with the bearing pads to assure a tight fit between the inner and outer booms.

Abstract: The present invention relates to a sodium salt of N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1H-pyrazole-3-sulfonamide and to hydrates, solvates and polymorphic forms thereof. The present invention further relates to pharmaceutical compositions comprising this compound and the use of this compound in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.

Abstract: The disclosure provides a plurality of particles. Each particle may include a material comprising 0.95 to 1.30 mole fraction Li, at least 0.60 and less than 1.00 mole fraction Co, up to 10,000 ppm Al, 1.90 to 2.10 mole fraction O, and up to 0.30 mole fraction M, where M is at least one element selected from B, Na, Mg, P, Ti, Ca, V, Cr, Fe, Mn, Ni, Cu, Zn, Al, Sc, Y, Ga, Zr, Ru, Mo, La, Si, Nb, Ge, In, Sn, Sb, Te, and Ce. Each particle may also include a surface composition comprising a mixture of LiF and a metal fluoride. An amount of fluorine (F) is greater than 0 and less than or equal to 5000 ppm. The metal fluoride comprises a material selected from the group consisting of AlF3, CaF2, MgF2, and LaF2. The surface composition may also include a metal oxide comprising a material selected from the group consisting of TiO2, MgO, La2O3, CaO, and Al2O3. An amount of the metal oxide is greater than 0 and less than or equal to 20000 ppm.

Abstract: Example methods and systems for contingency landing a UAV are provided, comprising sensors configured to detect a position of the UAV and a command module. The command module receives a mission profile comprising a travel path mapped out in multidimensional space over time from an origin to a destination, a first boundary circumscribing at least a portion of the travel path, a second boundary circumscribing the first boundary, and contingent landing sites. The command module sends instructions to the UAV to fly according to the mission profile and determines a position of the UAV relative to the first and the second boundaries. Responsive to determining that the UAV is positioned at the first boundary, the command module sends instructions to land at a contingent landing site, and responsive to determining that the UAV is positioned at the second boundary, the command module sends instructions to land immediately.

Abstract: An instrument may be coupled to a multi-axis expandable intervertebral cage so that the cage may be inserted into an intervertebral space, expanded along multiple different directions, filled with bone graft, and locked with a fastener. The instrument may be part of an instrument set that includes auxiliary instruments to determine implant size, insert bone graft into the cage, and deliver the fastener.

Abstract: Aspects of the disclosure relate to “wet” transcatheter prosthetic heart valve or other implant packaging and assemblies in which a prosthetic heart valve or other implant is loaded into a first portion of a delivery device and positioned within a container in which sterilizing fluid is retained to sterilize interior portions of the container as well as provide moisture to prevent the implant from drying out. The disclosure also relates to methods of sterilizing the disclosed assemblies. Some disclosed methods include at least two sterilizing steps and adjustment of a mechanical seal member or formation of multiple seals so that areas proximate the seals are also sterilized during the sterilization process.

Abstract: The present invention relates to a method for hedging a deferred compensation liability. In one embodiment, the invention may provide a mechanism to hedge the compensation expense liabilities of an employer providing deferred compensation to one or more employees.

Abstract: Disclosed herein is a cleaning device including a spray bottle, roller, and scrubber apparatus. The roller is positioned about the reservoir of the spray bottle. The removable scrubber is positioned in the base of the spray bottle. The roller uses a washable absorbent pad to clean surfaces with cleaning solution deposited by the spray bottle. The spray mechanism is held in two grips, a spray grip and a reverse grip in order to make use of the spray mechanism and the roller, respectively.

Abstract: Capping and cleansing devices for capping and cleansing needlefree connectors, particularly luer access devices such as needlefree vascular access connectors, and methods for using said devices, are described. The devices of the invention each include interconnected inner and outer housings that a user can transition between a locked or engaged position to allow the inner and outer housings to rotate in unison and an unlocked or disengaged position that allows the outer housing to rotate independently of the inner housing, and a compressible cleansing matrix secured in the device (preferably in a well in the outer housing).

Abstract: A composition of food or therapeutic and other substances for administration as a cloud of droplets, the cloud comprising readily-soluble droplets having a median size range of approximately 3 microns to approximately 20 microns, or 5 microns to 10 microns, or 6 microns to 10 microns, for introduction to an animal via an ortho-nasal or retro-nasal route. Agonists or antagonists may include one or more of the following: sodium iodide, sodium chloride, magnesium chloride, capsaicin, piperine, linalool, ground cinnamon, a cannabinoid, pimento, onion, clove, thyme, ginger, menthol, or TRPV antagonists, and chocolate, Irish cream, caramel, lemon, lime, mango, raspberry, watermelon, blueberry, strawberry, mint, popcorn, meat, Resolvin D2 or nicotine. Devices for delivering compositions as an aerosol are described.

Abstract: In one embodiment, a system comprising a network interface controller comprising circuitry to determine per-flow analytics information for a plurality of packet flows; and facilitate differential rate processing of a plurality of packet queues for the plurality of packet flows based on the per-flow analytics information.

Abstract: An emergency ventilation system ventilates a patient and includes a chamber housing defining a breathing chamber; a piston; and a motor operably connected to the piston. The motor applies an exhalation force to move the piston in an exhalation direction applies an inhalation force to move the piston in an inhalation direction. The piston increases air in the breathing chamber as the exhalation force is applied and decreases air in the breathing chamber as the inhalation force is applied. An exhalation check valve allows airflow from the air source to the breathing chamber and not to allow airflow from the breathing chamber to the air source as the inhalation force is applied. An inhalation check valve allows airflow from the breathing chamber to the air output and not to allow airflow from the air output to the breathing chamber as the exhalation force is applied.